Bayer Aktiengesellschaft (ETR:BAYN)
22.08
-0.50 (-2.19%)
Mar 31, 2025, 4:16 PM CET
Bayer Aktiengesellschaft Revenue
In the year 2024, Bayer Aktiengesellschaft had annual revenue of 46.61B EUR, down -2.16%. Bayer Aktiengesellschaft had revenue of 11.73B in the quarter ending December 31, 2024, a decrease of -1.12%.
Revenue
46.61B
Revenue Growth
-2.16%
P/S Ratio
0.48
Revenue / Employee
514.49K
Employees
90,587
Market Cap
22.17B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 46.61B | -1.03B | -2.16% |
Dec 31, 2023 | 47.64B | -3.10B | -6.11% |
Dec 31, 2022 | 50.74B | 6.66B | 15.10% |
Dec 31, 2021 | 44.08B | 2.68B | 6.48% |
Dec 31, 2020 | 41.40B | -2.15B | -4.93% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck KGaA | 21.16B |
Siemens Healthineers AG | 22.67B |
Fresenius SE & Co. KGaA | 21.83B |
Sartorius Aktiengesellschaft | 3.38B |
Fresenius Medical Care AG | 19.34B |
Carl Zeiss Meditec AG | 2.08B |
Fielmann Group AG | 2.16B |
SCHOTT Pharma AG & Co. KGaA | 954.68M |
Bayer Aktiengesellschaft News
- 4 days ago - Elliott held talks with private equity as it considered new Bayer campaign - Financial Times
- 5 days ago - Bayer in licenses Puhe BioPharma’s cancer candidate - Seeking Alpha
- 5 days ago - Bayer acquires rights in Puhe BioPharma cancer drug candidate - Reuters
- 6 days ago - ACC.25: Bayer Presents New Investigational Heart Failure Data and Continued Portfolio Research in Chronic Kidney Disease in Type 2 Diabetes - Business Wire
- 6 days ago - Bayer told to pay almost $2.1bn over Roundup cancer link claim - Independent Ireland
- 6 days ago - Monsanto parent ordered to pay $2B in Roundup lawsuit damages - The Hill
- 6 days ago - Bayer Stock Slumps After Firm Ordered To Pay More Than $2B in Latest Roundup Case - Investopedia
- 7 days ago - Push-pull over glyphosate in Germany - EURACTIV.com